Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Export-Reliant Indian Drug Industry Faces Fall Of Rupee Value

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry is discovering it might not be as immune to the global financial crisis as previously believed. Indian pharmas normally would have been expected to continue reaping the rewards of drug exports still needed worldwide, but the value of the rupee has fallen enough to counterbalance any of those gains. Part of the negative impact is due to the fact the capital used to pay for products that India exports has to be weighed against the reduced value of the rupee. The situation means at least a temporary freeze on expansion through acquisitions and cutbacks of expenses by Indian drug makers. (Click here for more
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC066994

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel